<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font20">and </span>
   <span class="font16">aRMMs </span>
   <span class="font15">for </span>
   <span class="font13">were </span>
   <span class="font13">The </span>
   <span class="font12">products </span>
   <span class="font12">with </span>
   <span class="font12">study </span>
   <span class="font12">discontinuation </span>
   <span class="font12">medicines </span>
   <span class="font12">risk </span>
   <span class="font12">was </span>
   <span class="font11">time </span>
   <span class="font11">{background </span>
   <span class="font11">introduction </span>
   <span class="font11">authorised </span>
   <span class="font11">post-authorisation </span>
   <span class="font11">that </span>
   <span class="font11">are </span>
   <span class="font11">safety </span>
   <span class="font11">measures </span>
   <span class="font11">margin </span>
   <span class="font11">minimisation </span>
   <span class="font11">not </span>
   <span class="font11">years </span>
   <span class="font11">from </span>
   <span class="font11">our </span>
   <span class="font11">studies </span>
   <span class="font11">which </span>
   <span class="font11">{border-style </span>
   <span class="font11">after </span>
   <span class="font11">data </span>
   <span class="font11">effectiveness </span>
   <span class="font11">included </span>
   <span class="font11">information </span>
   <span class="font11">may </span>
   <span class="font11">probability </span>
   <span class="font11">medicinal </span>
   <span class="font11">px;} </span>
   <span class="font11">within </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">all </span>
   <span class="font11">European </span>
   <span class="font10">[]. </span>
   <span class="font10">authorisation </span>
   <span class="font10">between </span>
   <span class="font10">during </span>
   <span class="font10">important </span>
   <span class="font10">product </span>
   <span class="font10">REMS </span>
   <span class="font10">discontinued </span>
   <span class="font10">evaluation </span>
   <span class="font10">have </span>
   <span class="font10">introduced </span>
   <span class="font10">reports </span>
   <span class="font10">aRMMs. </span>
   <span class="font10">use </span>
   <span class="font10">MA, </span>
   <span class="font10">aRMMs, </span>
   <span class="font10">new </span>
   <span class="font10">one </span>
   <span class="font10">risks </span>
   <span class="font10">this </span>
   <span class="font10">used </span>
   <span class="font10">without </span>
   <span class="font10">Spontaneous </span>
   <span class="font10">trials </span>
   <span class="font10">DHPCs </span>
   <span class="font10">Medicines </span>
   <span class="font10">additional </span>
   <span class="font10">available </span>
   <span class="font10">distribution </span>
   <span class="font10">educational </span>
   <span class="font10">following </span>
   <span class="font10">life </span>
   <span class="font10">materials </span>
   <span class="font10">sources </span>
   <span class="font10">these </span>
   <span class="font10">For </span>
   <span class="font10">concerned </span>
   <span class="font10">first </span>
   <span class="font10">had </span>
   <span class="font10">module </span>
   <span class="font10">more </span>
   <span class="font10">pharmacovigilance </span>
   <span class="font10">programme </span>
   <span class="font10">px; </span>
   <span class="font10">{font-family </span>
   <span class="font10">All </span>
   <span class="font10">Clinical </span>
   <span class="font10">Drug </span>
   <span class="font10">Europe </span>
   <span class="font10">aRMM </span>
   <span class="font10">active </span>
   <span class="font10">and/or </span>
   <span class="font10">approved </span>
   <span class="font10">assessment </span>
   <span class="font10">authorisation. </span>
   <span class="font10">changes </span>
   <span class="font10">controlled </span>
   <span class="font10">evidence </span>
   <span class="font10">font-size </span>
   <span class="font10">four </span>
   <span class="font10">healthcare </span>
   <span class="font10">identified </span>
   <span class="font10">low </span>
   <span class="font10">minimization </span>
   <span class="font10">non-innovator </span>
   <span class="font10">patients </span>
   <span class="font10">risks, </span>
   <span class="font10">systemic </span>
   <span class="font10">two </span>
   <span class="font10">EU-RMP </span>
   <span class="font10">Educational </span>
   <span class="font10">Netherlands </span>
   <span class="font10">Table </span>
   <span class="font10">authorisation, </span>
   <span class="font10">authors </span>
   <span class="font10">centrally </span>
   <span class="font10">clinical </span>
   <span class="font10">concerns </span>
   <span class="font10">cycle </span>
   <span class="font10">double; </span>
   <span class="font10">due </span>
   <span class="font10">include </span>
   <span class="font10">management </span>
   <span class="font10">mandatory </span>
   <span class="font10">only </span>
   <span class="font10">potential </span>
   <span class="font10">prevention </span>
   <span class="font10">professionals </span>
   <span class="font10">regulatory </span>
   <span class="font10">required </span>
   <span class="font10">review </span>
   <span class="font10">study, </span>
   <span class="font10">study. </span>
   <span class="font10">substances </span>
   <span class="font10">system </span>
   <span class="font10">targeted </span>
   <span class="font10">their </span>
   <span class="font10">through </span>
   <span class="font10">type </span>
   <span class="font10">under </span>
   <span class="font10">â€".) </span>
   <span class="font10">(%) </span>
   <span class="font10">(N, </span>
   <span class="font10">(â€") </span>
   <span class="font10">B.V., </span>
   <span class="font10">GVP </span>
   <span class="font10">However, </span>
   <span class="font10">Ireland </span>
   <span class="font10">January </span>
   <span class="font10">Union </span>
   <span class="font10">access </span>
   <span class="font10">also </span>
   <span class="font10">annex </span>
   <span class="font10">approval </span>
   <span class="font10">benefitâ€"risk </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">content </span>
   <span class="font10">date </span>
   <span class="font10">drug </span>
   <span class="font10">extracted </span>
   <span class="font10">follow-up </span>
   <span class="font10">i.e. </span>
   <span class="font10">medication </span>
   <span class="font10">months </span>
   <span class="font10">most </span>
   <span class="font10">orphan </span>
   <span class="font10">other </span>
   <span class="font10">pregnancy </span>
   <span class="font10">programmes </span>
   <span class="font10">provide </span>
   <span class="font10">regarding </span>
   <span class="font10">reported </span>
   <span class="font10">rev </span>
   <span class="font10">routine </span>
   <span class="font10">shown </span>
   <span class="font10">solid; </span>
   <span class="font10">taken </span>
   <span class="font10">whether </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(%). </span>
   <span class="font10">ATC </span>
   <span class="font10">Additional </span>
   <span class="font10">Commons </span>
   <span class="font10">Controlled </span>
   <span class="font10">Creative </span>
   <span class="font10">Data </span>
   <span class="font10">Introduction </span>
   <span class="font10">Medical </span>
   <span class="font10">Observational </span>
   <span class="font10">PAS </span>
   <span class="font10">Products </span>
   <span class="font10">Studies </span>
   <span class="font10">XVI </span>
   <span class="font10">[â€"]. </span>
   <span class="font10">action </span>
   <span class="font10">aim </span>
   <span class="font10">aimed </span>
   <span class="font10">alfa) </span>
   <span class="font10">antigen </span>
   <span class="font10">any </span>
   <span class="font10">been </span>
   <span class="font10">bold </span>
   <span class="font10">collection </span>
   <span class="font10">conditional </span>
   <span class="font10">conducted </span>
   <span class="font10">considered </span>
   <span class="font10">containing </span>
   <span class="font10">corresponding </span>
   <span class="font10">could </span>
   <span class="font10">courier; </span>
   <span class="font10">describes </span>
   <span class="font10">down </span>
   <span class="font10">em; </span>
   <span class="font10">exceptional </span>
   <span class="font10">found </span>
   <span class="font10">further </span>
   <span class="font10">identify </span>
   <span class="font10">imposed </span>
   <span class="font10">intended </span>
   <span class="font10">involved </span>
   <span class="font10">marketing </span>
   <span class="font10">medicine </span>
   <span class="font10">missing </span>
   <span class="font10">needed </span>
   <span class="font10">observational </span>
   <span class="font10">performed </span>
   <span class="font10">period </span>
   <span class="font10">period, </span>
   <span class="font10">plan </span>
   <span class="font10">post-authorisation, </span>
   <span class="font10">practices </span>
   <span class="font10">pt;} </span>
   <span class="font10">rate </span>
   <span class="font10">rates </span>
   <span class="font10">reviewed </span>
   <span class="font10">scientific </span>
   <span class="font10">scope </span>
   <span class="font10">should </span>
   <span class="font10">spontaneous </span>
   <span class="font10">steps </span>
   <span class="font10">studies, </span>
   <span class="font10">such </span>
   <span class="font10">than </span>
   <span class="font10">tract </span>
   <span class="font10">use. </span>
   <span class="font10">using </span>
   <span class="font10">when </span>
   <span class="font10">â€œEPARâ€"Procedural </span>
   <span class="font10">â€œEPARâ€"Public </span>
  </p>
 </body>
</html>
